iCAD Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ICAD Nasdaq 3845 https://www.icadmed.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for iCAD Inc

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium - Apr 11th, 2024 12:00 pm
iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation - Apr 9th, 2024 12:00 pm
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting - Apr 8th, 2024 8:29 pm
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs) - Apr 3rd, 2024 12:00 pm
iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale - Apr 2nd, 2024 12:00 pm
iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists - Mar 19th, 2024 1:00 pm
Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market - Mar 14th, 2024 6:00 pm
iCAD, Inc. (NASDAQ:ICAD) Q4 2023 Earnings Call Transcript - Mar 13th, 2024 12:46 pm
Q4 2023 ICAD Inc Earnings Call - Mar 13th, 2024 11:01 am
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results - Mar 12th, 2024 8:01 pm
Investors in iCAD (NASDAQ:ICAD) from three years ago are still down 87%, even after 44% gain this past week - Mar 5th, 2024 10:46 am
The Hot List: 3 AI Stocks Worth Buying on Weakness - Mar 1st, 2024 12:30 pm
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings - Feb 28th, 2024 1:05 pm
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ) - Feb 27th, 2024 2:05 pm
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 - Feb 27th, 2024 1:05 pm
iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Feb 6th, 2024 1:00 pm
iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member - Jan 30th, 2024 1:00 pm
iCAD Expands Executive Sales Leadership Team as Business Grows - Dec 18th, 2023 1:00 pm
Wealth Accumulation: 3 Stocks with Multibagger Potential - Dec 5th, 2023 11:00 am
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare - Nov 28th, 2023 1:00 pm